ADALIMUMAB (ADL) - ANVISA Registration 80134860240
Access comprehensive regulatory information for ADALIMUMAB (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860240 and manufactured by PROGENIKA BIOPHARMA S.A.. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including BUHLMANN LABORATORIES AG, BODITECH MED INC., and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80134860240
25351310815201652
02513899000171
Company Information
Dates and Status
Jul 03, 2017
VIGENTE
09/18/2025 19:00:01
ADALIMUMAB (ADL)
IDKmonitor® Adalimumab drug level ELISA
IMMUNDIAGNOSTIK
80464810758
Feb 04, 2021
ADALIMUMAB (ADL)
BÜHLMANN Quantum Blue® Adalimumab
BUHLMANN LABORATORIES AG
80102512062
Jun 25, 2018
INFLIXIMAB (IFX)
PROMONITOR IFX
PROGENIKA BIOPHARMA S.L.
80134860242
Jul 03, 2017
ETANERCEPT (ETN)
PROMONITOR ETN
PROGENIKA BIOPHARMA S.A.
80134860237
Jul 03, 2017
INFLIXIMAB (IFX)
IDKmonitor® Infliximab drug level ELISA
IMMUNDIAGNOSTIK AG
80464810919
May 05, 2025
ADALIMUMAB (ADL)
Família AFIAS Adalimumab
BODITECH MED INC.
10350840428
Oct 27, 2022
ADALIMUMAB (ADL)
IDKmonitor® Adalimumab drug level ELISA
IMMUNDIAGNOSTIK
80464810758
Feb 04, 2021
ADALIMUMAB (ADL)
BÜHLMANN Quantum Blue® Adalimumab
BUHLMANN LABORATORIES AG
80102512062
Jun 25, 2018